On the other hand, in 7 cancer types, the survival rate was significantly lower among patients whose tumors had high levels of NEAT1 expression than among those with low NEAT1 expression in tumors (colon adenocarcinoma (COAD), glioblastoma multiforme (GBM), KIRC, lower grade glioma (LGG), THYM, uterine corpus endometrial carcinoma (UCEC), and uveal melanoma (UVM)) (“Poor” in “Total” column of Table 1). This evidence concerns the gene NEAT1 and glioma.